Transaction · 0001193125-26-382450
CORTCORCEPT THERAPEUTICS INC
Lyon Joseph Douglas
Lyon Joseph Douglas, SR, reported a transaction classified as withholding at CORCEPT THERAPEUTICS INC involving 72.000000 shares for an estimated $8163.36. Reported holdings after the transaction were 5683.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
withholdingSEC transaction code FSR
- Trade date
- Sep 02, 2026
- Filing date
- Sep 04, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CORT price since this filing
Daily closing prices, with the filing date and available return windowsCORT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +1.1%1w ago +7.3%1d ago +1.6%
Returns since7d +1.0%30d +4.1%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001193125-26-382450 Common Stock
- Transaction date
- Sep 02, 2026 Filed Sep 04, 2026, 01:00 AM · 2d delay
- Shares
- 72 sh $113.38 per share
- Estimated value
- -$8.16k Computed from shares × price
- Holdings after
- 5,683 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
See Remarks
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 I…
- F2
In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- F3
Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to th…
- F4
Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-y…
- F5
These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- F6
The closing price on September 1, 2026 was used to calculate the withholding obligation.
- F7
Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the…
Related transactions
Same SEC filing0 other transactions
Recent company activity
CORT0 recent txs